LivingGLP1
parallel randomized trial

S003092

Design

Randomized
117
Start year
2009
Treatment
12 weeks, follow-up 12 weeks
Countries
China
Sponsor
(not reported)
Eligibility
T2DM with ultrasound NAFLD; FBG 6.0 to 10.0 mmol/L or HbA1c 7 to 9 percent

Conduct and analysis

Blinding
not reported
Sequence generation
not reported
Allocation concealment
not reported
Outcome adjudication
not reported
Primary estimand
not stated
Analysis population
completers
Missing data
completers only

Arms

ArmTreatmentBackgroundRandomizedAnalyzedCompleted treatment
A1Exenatide 10 ug subcutaneous twice daily
Exenatide 10 ug twice daily
lifestyle: standard49
A2Metformin
Metformin
lifestyle: standard68

Baseline characteristics

As printed in the trial reports or registry, per arm or for the whole trial.
CharacteristicStatisticExenatide 10 ug subcutaneous twice daily
A1
Metformin
A2
agemean (years)51.0254.68
agesd (years)10.1012.14
bmimean (kg/m2)28.1827.61
bmisd (kg/m2)1.861.77
femalen2130
hba1cmean (percent)8.148.09
hba1csd (percent)0.510.59
weightmean (kg)80.6178.58
weightsd (kg)11.2310.76

Results

11 adjudicated result lines, grouped by outcome. Open an outcome to see its values.
HbA1c change (4 lines; O01)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
12A1change-0.91 percent0.6549not stated; completers; R0026372:Table 3
12A1final7.15 percent0.3649not stated; completers; R0026372:Table 2
12A2change-0.89 percent0.5768not stated; completers; R0026372:Table 3
12A2final7.16 percent0.5868not stated; completers; R0026372:Table 2
Body weight change in kilograms (diabetes) (4 lines; O02)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
12A1change-4.16 kg5.3249not stated; completers; R0026372:Table 3
12A1final76.09 kg9.8549not stated; completers; R0026372:Table 2
12A2change-1.98 kg3.2868not stated; completers; R0026372:Table 3
12A2final77.22 kg10.1568not stated; completers; R0026372:Table 2
HbA1c below 7 percent (2 lines; O03)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
12A1responders18 / 49not stated; completers; R0026372:Table 4
12A2responders28 / 68not stated; completers; R0026372:Table 4
Diarrhea (1 lines; O27C)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A2events3 / 68not stated; completers; R0026372:Results